Glucotrack Prices $3.1M Registered Direct Offering at $2.04/Share
GCTK sits 33% above its 52-week low of $1.998 on elevated volume (25× avg).
Summary
Glucotrack priced a $3.1 million registered direct offering of common stock and pre-funded warrants, with proceeds earmarked for debt repayment and working capital.
Updates
· SEC 424B5 — The 424B5 prospectus supplement details the offering: 169,388 shares at $2.04 and 1,350,220 pre-funded warrants at $2.039, gross proceeds $3.1 million, net proceeds approximately $2.85 million, closing expected September 25, 2026.
Key Events · Financing and Capital Events · GCTK
-
Registered Direct Offering Priced
169,388 shares at $2.04 per share plus pre-funded warrants for 1,350,220 shares at $2.039 per warrant, for gross proceeds of approximately $3.1 million.
-
Dilution Impact
The offering adds up to 1,519,608 shares of common stock on a fully-exercised basis, a substantial increase relative to the company's current share count.
-
Use of Proceeds
Net proceeds will be used to pay off existing debt, with the remainder for working capital and general corporate purposes.
-
Placement Agent Compensation
Dawson James Securities will receive an 8.0% cash fee on gross proceeds, plus expense reimbursements.
Analysis · GCTK · Industrial Applications And Services
Glucotrack priced a $3.1 million registered direct offering at $2.04 per share, with pre-funded warrants covering an additional 1.35 million shares. The deal is priced at-the-market under Nasdaq rules, so it does not carry a deep discount to the reference price, but it adds meaningful dilution for a company with a market cap near $2 million. Proceeds will pay down existing debt and fund working capital, extending runway for a company that disclosed going-concern doubt in its last 10-Q. The six-month equity issuance lock-up and 90-day insider lock-ups are standard but notable given the company's recent history of frequent dilutive financings.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.9% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GCTK was trading at $2.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $2.00 to $136.29. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.